Total Funding
42
26
Total FundingPost-IPO Equity raised
Growth Score
-3 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
207919
VBL Therapeutics is a clinical-stage platform company developing targeted therapies for immune-inflammatory diseases.
Dror Harats: CEO
Jide Zeitlin: COO
Notable Labs
About the Company
VBL Therapeutics is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel treatments for cancer and immune-inflammatory diseases.
VBL’s clinical pipeline is based on two distinct, proprietary platform technologies that leverage the body’s natural physiologic and genetic regulatory elements.
